Invest in the Renaissance Institute

---

At Renaissance Institute, we are reimagining the future of oncology and radiosurgery with a facility that combines state-of-the-art technology, renowned expertise, and a focus on precision therapies that are unmatched in the field. We invite investors to become part of this journey, offering both the potential for strong returns and the fulfillment of contributing to life-changing healthcare innovations.

Renaissance Partners LLC brings together a highly specialized team and cutting-edge technology to create a center of excellence that is uniquely positioned to capitalize on the growing demand for advanced radiotherapy and radiosurgery treatments. Key differentiators include:

• World-Class Technology: Equipped with top-tier machines, including the Varian Edge and Siemens 3T VIDA MRI, we are capable of delivering unparalleled treatment precision for even the most complex cases.
• Unmet Patient Demand: Situated in Winter Park, Florida, our center is in a prime location, with proximity to major airports and a rapidly expanding population of retirees who increasingly seek access to high-quality healthcare. The absence of major competing academic centers in the area enhances our position as a preferred choice for specialized care.
• Innovative Treatment Solutions: Our range of services includes advanced radiosurgical treatments for not just cancer but pain, movement disorders, cardiac dysrhythmias, and more. This unique combination of services meets a critical need in the healthcare market.

The market for advanced oncology and radiosurgery solutions is experiencing robust growth, driven by technological advancements and an increased focus on personalized, non-invasive treatments. By investing in Renaissance Partners LLC, you’re investing in a facility poised for long-term growth, with a strategic plan to expand services, increase patient volume, and explore potential future partnerships and mergers.

Under the leadership of Dr. Evan Thomas and Dr. Pantaleo Romanelli, the institute has not only secured partnerships with leading equipment manufacturers but has also raised significant capital from trusted investors who recognize the immense value of our vision. With this strong financial foundation, we’re set to maximize our revenue potential through optimized operational efficiencies, strategic payer credentialing, and expansion into underserved patient demographics.

We believe that our innovative model and exceptional team offer a unique investment opportunity in a field where patient outcomes and financial success go hand in hand. Join us in pioneering the next generation of oncology and radiosurgery, and be part of a high-impact investment that delivers both meaningful returns and a legacy of improved lives.